Sigma Planning Corp - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 151 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$80,000
-20.8%
73,000
+32.0%
0.00%
-33.3%
Q3 2021$101,000
+140.5%
55,310
+230.2%
0.00%
+200.0%
Q4 2020$42,000
-26.3%
16,750
-25.4%
0.00%
-50.0%
Q3 2020$57,000
-1.7%
22,450
+26.5%
0.00%
-33.3%
Q2 2020$58,000
+81.2%
17,750
+36.5%
0.00%
+50.0%
Q1 2020$32,000
-80.0%
13,000
-52.5%
0.00%
-75.0%
Q2 2019$160,00027,3800.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$38,182,0007.99%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 10,406,850$26,225,0004.02%
MILLER VALUE PARTNERS, LLC 12,385,586$31,211,0001.12%
CHIRON CAPITAL MANAGEMENT, LLC 201,470$508,0000.41%
Sargent Investment Group, LLC 289,025$728,0000.26%
MAGNOLIA CAPITAL ADVISORS LLC 80,542$404,0000.16%
XTX MARKETS LLC 11,086$28,0000.14%
Virtus ETF Advisers LLC 99,108$250,0000.13%
Old West Investment Management, LLC 210,226$529,0000.12%
EQUITEC PROPRIETARY MARKETS, LLC 31,300$79,0000.06%
View complete list of ZIOPHARM ONCOLOGY INC shareholders